Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.
Medherant has raised $3.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
Medherant's investors include Innovate UK, Mercia Asset Management.
Medherant is headquartered in Coventry, United Kingdom.
Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.
Medherant is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Medherant — Funding & Investors." VCBacked, April 3, 2023, https://www.vcbacked.co/company/medherant. Accessed August 14, 2026.
VCBacked. (2023). Medherant — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/medherant
{{cite web |title=Medherant — Funding & Investors |url=https://www.vcbacked.co/company/medherant |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated